NCT04567992

Brief Summary

The essential goal for tracheal reconstruction is is the ability of the anaesthesiologist and surgeon to maintain control of the airway at all times. In the postoperative period the patient should maintain a flexed neck position to avoid any traction on the tracheal anastomosis. Thus, pain control is essential postoperatively so that patients will be awake and cooperative to maintain this position. \[1\]. Superficial cervical plexus block can be used in a variety of surgical procedures , including superficial surgery on the neck and shoulders and thyroid surgery as it results in anesthesia of the skin of the anterolateral neck and the ante-auricular and retro-auricular areas, as well as the skin overlying and immediately inferior to the clavicle on the chest wall Figures 1 and 6)\[2\]. Thus it can be used as an adjuvant to general anaesthesia to provide analgesia for patients undergoing tracheal resection and anastomosis to keep the patients awake and cooperative at the conclusion of the procedure. The goal of the ultrasound (US)-guided technique of SCB is to deposit local anesthetic within the vicinity of the sensory branches of the nerve roots C2, C3, and C4 which combine to form the four terminal branches (the lesser occipital, greater auricular, transverse cervical, and supraclavicular nerves) and emerge from behind the posterior border of the SCM. Advantages over the landmark-based technique include the ability to visualize the spread of local anesthetic in the correct plane, which therefore increases the success rate, and to avoid a needle insertion that is too deep and the inadvertent puncture of neighboring structures\[3\]. Aim of the work To assess the efficiency of using ultrasound-guided SCB for providing intra and postoperative analgesia for patients undergoing tracheal resection and anastomosis under general anaesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 29, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

February 14, 2022

Status Verified

October 1, 2020

Enrollment Period

4 months

First QC Date

September 24, 2020

Last Update Submit

February 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • quality of recovery using quality of recovery 40 qusetionnaire

    total score of Qor-40 (total score of 200) with highest indicates better outcome

    first 24 hour

Secondary Outcomes (2)

  • post operative morphine consumption

    24 hour

  • visual analogue scale post-operative

    first 24 hour

Study Arms (2)

SCPB

EXPERIMENTAL
Procedure: superficial cervical plexus block

Control

PLACEBO COMPARATOR
Procedure: superficial cervical plexus block

Interventions

ultrasound guided injection of local anaesthesia in the superficial cervical plexus

Also known as: Drug:, Bupivicaine
ControlSCPB

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA physical status I, II, and III adult patients undergoing elective tracheal resection and anastomosis under general anaesthesia were included.

You may not qualify if:

  • Coagulation disorders
  • Pregnancy.
  • Age less than 18 years.
  • Patient refusal.
  • Emergency re-operation within

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr alainy medical school

Cairo, 12566, Egypt

Location

MeSH Terms

Interventions

Pharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of anaesthesia, SICU and pain management

Study Record Dates

First Submitted

September 24, 2020

First Posted

September 29, 2020

Study Start

November 1, 2020

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

February 14, 2022

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations